Described herein are pharmaceutical packaging units which protect against oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive medication, such devices which includes a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxygen